Kirkland Advises GTCR and Sterigenics International in Recapitalization

Kirkland & Ellis LLP represented private equity firm GTCR and Sterigenics International, the leading global provider of mission-critical sterilization services to the medical device, pharmaceutical, food safety and high-performance materials industries, which today announced that it will recapitalize Sterigenics with an affiliate of Warburg Pincus, a global private equity firm focused on growth investing. Terms of the transaction were not disclosed. GTCR purchased Sterigenics in 2011. More information on the transaction is available here.

The Kirkland team included corporate partners Sanford Perl and Michael Weed and corporate associates John Berger, Evan Knobloch  and Ryan Jackson.  The team also included financing partners Christopher Butler, Robert Goedert, Dennis Myers and Amy Peters, tax partner Russell Light and associate Joel Peters-Fransen, employee benefit and labor partners Alexandra Mihalas and Tim Stephenson and associate Erica Buerger, real estate partner John Caruso, intellectual property partner Seth Traxler and associate William Helmstetter, environmental partner Brian Land and associate Stefanie Gitler and international trade partner Joanna Ritcey-Donohue and associate Roxana Mondragon-Motta.